TiGenix completes recruitment for arthritis trial

BRUSSELS (Reuters) - Belgian biotechnology firm TiGenix has recruited enough patients to start a mid-stage trial for its stem cell-based treatment for rheumatoid arthritis, it said on Wednesday.

via Reuters: Health News Read More Here..